These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18179684)

  • 21. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
    Mehta K; Fok J; Miller FR; Koul D; Sahin AA
    Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of tammar (Macropus eugenii) mammary epithelial cells stimulated with lipopolysaccharide and lipoteichoic acid.
    Daly KA; Mailer SL; Digby MR; Lefévre C; Thomson P; Deane E; Nicholas KR; Williamson P
    Vet Immunol Immunopathol; 2009 May; 129(1-2):36-48. PubMed ID: 19157568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells.
    Pugazhendhi D; Sadler AJ; Darbre PD
    J Appl Toxicol; 2007; 27(1):67-77. PubMed ID: 17121429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
    Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D
    Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome.
    Oh EY; Wood PA; Yang X; Hrushesky WJ
    Breast Cancer Res Treat; 2009 Nov; 118(2):345-59. PubMed ID: 19051007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.
    Iacobuzio-Donahue CA; Argani P; Hempen PM; Jones J; Kern SE
    Cancer Res; 2002 Sep; 62(18):5351-7. PubMed ID: 12235006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
    Santin AD; Zhan F; Bignotti E; Siegel ER; Cané S; Bellone S; Palmieri M; Anfossi S; Thomas M; Burnett A; Kay HH; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Virology; 2005 Jan; 331(2):269-91. PubMed ID: 15629771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors.
    Alaoui-Jamali MA; Song DJ; Benlimame N; Yen L; Deng X; Hernandez-Perez M; Wang T
    Cancer Res; 2003 Jul; 63(13):3764-74. PubMed ID: 12839972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
    Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
    J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of new genes differentially expressed in breast carcinoma cells treated with human chorionic gonadotropin.
    Srivastava P; Silva ID; Russo J; Mgbonyebi OP; Russo IH
    Int J Oncol; 1998 Sep; 13(3):465-9. PubMed ID: 9683780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential gene expression profile in breast cancer-derived stromal fibroblasts.
    Singer CF; Gschwantler-Kaulich D; Fink-Retter A; Haas C; Hudelist G; Czerwenka K; Kubista E
    Breast Cancer Res Treat; 2008 Jul; 110(2):273-81. PubMed ID: 17899370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
    Martin TA; Harrison GM; Watkins G; Jiang WG
    J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
    Jones RA; Campbell CI; Petrik JJ; Moorehead RA
    Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-derived CCL5 does not contribute to breast cancer progression.
    Jayasinghe MM; Golden JM; Nair P; O'Donnell CM; Werner MT; Kurt RA
    Breast Cancer Res Treat; 2008 Oct; 111(3):511-21. PubMed ID: 17978871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.